Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 2 out of 10 pages
Exam (elaborations)

ALU 201 Exam (Chapter 10) – Questions With Fully Explained Solutions 2026

Document preview thumbnail
Preview 2 out of 10 pages

This document contains Q&A-style definitions covering rheumatology and musculoskeletal disorders. Topics include: ankylosing spondylitis, reactive arthritis (classic triad: arthritis, urethritis, conjunctivitis), polyarteritis nodosa, Raynaud's phenomenon, vasculitis types (Wegener's granulomatosis, temporal arteritis), scleroderma, rheumatoid arthritis (poor prognosis factors, DMARDs, biologic therapies, extra-articular manifestations), osteoporosis (risk factors, prevention), psoriatic arthritis, gout (diagnosis, treatment, allopurinol), pseudogout (CPPD), systemic lupus erythematosus (SLE classification criteria, prognosis), polymyositis, dermatomyositis, polymyalgia rheumatica, giant cell arteritis, osteomalacia, Paget's disease, osteoarthritis (DISH, inactivity gelling), Felty's syndrome, Sjogren's syndrome, HLA-B27 and seronegative spondyloarthropathies, and lupus survival rates. Each answer is clearly highlighted. Ideal for rheumatology, internal medicine, NP, PA, and medical exam preparation.

Content preview

ALU 201 Exam (Chapter 10) –
Questions With Fully Explained
Solutions 2026
1. Ankylosing spondylitis

Answer: An inflammatory disorder of the spine that can also involve the peripheral joints. Diagnosis is
usually based on clinical features, including loss of spinal motion, decreased chest expansion, and
inflammatory back pain.



2. Reactive arthritis

Answer: Typically begins after an acute diarrheal illness caused by various bacteria. This form of
seronegative arthritis is more common in men. Alternatively, it can begin after a venereal infection, such
as chlamydia. The classic triad of reactive arthritis is: 1. arthritis (asymmetric oligoarthritis of lower
extremity joints, can involve the spine similarly to ankylosing spondylitis), 2. urethritis, 3. conjunctivitis.



3. Polyarteritis nodosa (PAN)

Answer: Characterized by inflammation in the walls of blood vessels of various sizes. PAN is one example
of a disorder linked to hepatitis B infection in many cases.



4. Raynaud's phenomenon

Answer: Refers to the paroxysmal pallor or cyanosis of the digits of the hands and feet where body
temperature is at its lowest.



5. Types of vasculitis

Answer: Polyarteritis nodosa, Wegener's granulomatosis, temporal arteritis.



6. Polyarteritis nodosa (medium vessel vasculitis)

Answer: Is a prime example of a medium vessel vasculitis (MVV) affecting the arteries that contain
muscular walls. The damage caused by the inflammation leads to aneurysmal formation.

, 7. Wegener's granulomatosis

Answer: A vasculitis of the small and medium vessels, affects approximately one in 20,000-30,000
people. WG affects primarily the lungs and kidneys but is not overtly apparent early in the course of the
disease.



8. Temporal arteritis

Answer: Is characterized by inflammatory changes in one of the branches of the aorta, occurring almost
exclusively in individuals older than 50 years.



9. Scleroderma (systemic sclerosis)

Answer: Autoimmune disease characterized by skin hardening, can cause scarring and fibrosis in the
lungs.



10. Factors associated with poor prognosis in rheumatoid arthritis

Answer: 1. Male gender; 2. Early functional disability; 3. High titer of rheumatoid factor or antibodies to
CCP; 4. Early development of radiologic erosions; 5. Extra-articular manifestations.



11. Types of treatment for rheumatoid arthritis

Answer: Disease-modifying anti-rheumatic drugs (DMARDs), such as methotrexate (Rheumatrex®);
antimalarial drugs, such as hydroxychloroquine (Plaquenil®); sulfasalazine (Azulfidine®) and leflunomide
(Arava®); "Biologic" therapies targeted at inflammatory mediators, such as TNF-alpha inhibitors that
include adalimumab (Humira®), infliximab (Remicade®), golimumab (Simponi®), certolizumab pegol
(Cimzia®), and etanercept (Enbrel®).



12. Risk factors for primary osteoporosis

Answer: 1. Increased age; 2. Female gender; 3. Early menopause (whether natural or as a result of
surgery); 4. Smoking; 5. Heavy alcohol use. Physical inactivity and thin body type are also predictors, as
is a family history of osteoporosis.



13. Preventative measures for osteoporosis

Answer: A good intake of calcium is the most important measure in this regard. The mainstay of
osteoporosis therapy is bisphosphonate treatment.

Document information

Uploaded on
April 28, 2026
Number of pages
10
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$8.19

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
1
Followers
0
Items
57
Last sold
4 months ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions